The CAV1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT29 human colorectal adenocarcinoma cell line. This engineered model introduces a targeted disruption of the CAV1 gene, leading to loss of caveolin-1 protein expression and providing a robust platform for studying the functional roles of caveolin-1 in colorectal cancer. As a polyclonal population, these cells capture the heterogeneity of genome editing outcomes, allowing researchers to examine caveolin-1-dependent processes without the bias of a single clonal isolate.
HT29 cells are a well-established epithelial colorectal adenocarcinoma line harboring mutations in the tumor suppressors APC and TP53, as well as the oncogene KRAS. These cells retain the capacity for enterocytic differentiation under appropriate culture conditions, making them a versatile model for investigating intestinal tumorigenesis, epithelial-mesenchymal plasticity, and drug responses. Their origin from a primary colorectal tumor renders them highly relevant for studying human colorectal cancer biology and the impact of oncogenic signaling alterations.
Caveolin-1, encoded by CAV1, is the primary coat protein of caveolae and functions as a scaffolding molecule that integrates membrane trafficking, cholesterol homeostasis, and signal transduction. It directly interacts with Src family kinases, H-Ras, G-proteins, integrin beta1, EGFR, and flotillin. Regulated by upstream factors such as EGF, TGF-beta, insulin, and cholesterol, caveolin-1 modulates downstream effectors including eNOS, MAPK/ERK, Rho GTPases, STAT3, and Cyclin D1. Caveolin-1 organizes integrin, EGFR, TGF-beta, and PI3K/AKT pathways within caveolae, positioning it as a context-dependent tumor modulator.
In the HT29 background, loss of caveolin-1 disrupts caveolae formation and caveolin-mediated endocytosis, leading to altered integrin-mediated adhesion and dysregulation of growth factor signaling. This model perturbs Src/FAK and ERK1/2-Akt cascades, influencing cell proliferation, migration, and survival central to colorectal cancer progression. The polyclonal population avoids clonal artifacts and reflects stochastic gene disruption, enabling robust analysis of caveolin-1??s role in oncosuppressive or oncogenic mechanisms.
These CAV1 knockout HT29 polyclonal cells are applicable in colorectal cancer biology, tumor microenvironment studies, metastasis, drug resistance, and signal transduction research. Representative assays include Western blotting for caveolin-1 and phospho-proteins, RT-qPCR for CAV1 and targets, proliferation and migration assays, co-immunoprecipitation of caveolin-1 complexes, and drug sensitivity screens. Integrating HT29 models with CAV1 disruption provides a powerful system for dissecting caveolin-1-dependent signaling in colorectal cancer. For further details or technical support, please contact Ascent Research.
